GDUFA Facility Fees Should Be Waived Until First ANDA Approved, Petition Argues

Bangladesh-based Square Pharmaceuticals says the fees are burdensome for first-time filers, given long approval times, but the firm’s citizen petition strategy may further delay approval of its ANDA.